Addyi was very first authorized with the FDA in August 2015 to take care of hypoactive sexual desire disorder (HSDD) in premenopausal Females. That is just yet another way of claiming it boosts sexual intercourse travel (also known as libido) in women who've not attained menopause. It was the in